The effect of the inhibition of PGI2-synthetase and lipoxygenase and of arachidonic acid on platelet-vessel wall interaction.
D000818:Animals; D001095:Arachidonic Acids / Q000494:pharmacology*; D001792:Blood Platelets / Q000187:drug effects*; D001808:Blood Vessels / Q000187:drug effects*; D003577:Cytochrome P-450 Enzyme System; D011464:Epoprostenol / Q000037:antagonists & inhibitors / Q000096:biosynthesis*; D019746:Intramolecular Oxidoreductases; D016859:Lipoxygenase Inhibitors; D008297:Male; D011422:Propionates / Q000494:pharmacology; D011453:Prostaglandins / Q000096:biosynthesis*; D051381:Rats; D011919:Rats, Inbred Strains; D014191:Tranylcypromine / Q000494:pharmacology
D001095:Arachidonic Acids; D016859:Lipoxygenase Inhibitors; D011422:Propionates; D011453:Prostaglandins; C011677:benoxaprofen; D014191:Tranylcypromine; D003577:Cytochrome P-450 Enzyme System; D011464:Epoprostenol; D019746:Intramolecular Oxidoreductases; C022461:prostacyclin synthetase